CHICAGO — Adults with elevated liproprotein(a) at high risk for a CV event saw substantial reductions over 12 weeks with muvalaplin, an investigational oral small molecule Lp(a) inhibitor, data from a phase 2 study show.Evidence for a causal association between Lp(a) concentration, which is primarily genetically determined, and CV outcomes across ethnicities continues to build, and data
The latest news from the AHA Scientific Sessions, with physician perspective, researcher interviews and clinician insight on cardiovascular prevention and more.
AbstractBackgroundObesity is a known risk factor for heart failure with preserved ejection fraction (HFpEF) and is considered a distinct phenotype with more concentric remodeling. Epicardial…
CHICAGO — Treatment with the heart failure medication sacubitril/valsartan was associated with a lower risk for chemotherapy-related heart damage among high-risk patients with cancer, according…
CHICAGO — People living in historically redlined neighborhoods with poor access to healthy foods were more likely to have type 2 diabetes, hypertension, coronary heart…
During assessments of episodic memory, processing speed, and inhibition and attention, children with vs. without asthma had poorer scores, according to results published in JAMA…
SAN ANTONIO — Obesity medications, regardless of class or generation, were associated with reduced alcohol intake among individuals participating in a telehealth weight-loss program, a…
The latest news from the ACR Annual Meeting, including perspectives and interviews with leading researchers and clinicians, plus archives of past meetings.
Among adult smokers who moved from smoking cigarettes to e-cigarettes exclusively, wheeze resolution went up, but this was not the case if they moved to…
The latest news from the ACR Annual Meeting, including perspectives and interviews with leading researchers and clinicians, plus archives of past meetings.
SAN DIEGO — Liver stiffness measurements may help predict the risk for hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease, as well as…
